ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

58 hedge funds and large institutions have $419M invested in Adverum Biotechnologies in 2014 Q3 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$114M
2
+$70M
3
+$42.8M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$34.2M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$25M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$114M
2
$70M
3
$42.8M
4
$34.2M
5
$25M
6
$21.5M
7
$15.3M
8
$13.5M
9
$10.3M
10
$8.5M
11
$6.68M
12
$5.81M
13
$5.19M
14
$4.1M
15
$3.98M
16
$3.49M
17
$3.42M
18
$2.22M
19
$1.96M
20
$1.94M
21
$1.83M
22
$1.77M
23
$1.71M
24
$1.58M
25
$1.57M
1
2 3